Home / Locations / France / Strasbourg
CMS BFL Strasbourg



Spurred by the strong economical potential of the region, the firm opened the Strasbourg office in 2003 in order to diversify the geographical origin of its clients and to complete the presence of the CMS alliance in France. Our Practice AreasNational and International Tax Law Tax audits, litigation and collections claims Restructuring Real-estate taxation Computerized accounting verification assistance International transaction taxation Structuring of investments outside France and of foreign investments in France Tax auditsCorporate Law Company law Mergers & Acquisitions, restructuring Equity engineering Contracts Sale of business and clientele  Legal reviewsLitigation & Arbitration Economic litigation Commercial litigation

more less



more less


CMS Francis Lefebvre Avocats
1 rue du Maréchal Joffre
67083 Strasbourg
Open Google Maps


Tech­no­logy Trans­form­a­tion: Man­aging Risks in a Chan­ging Land­scape
Chan­ging tech, chan­ging risks
Reg­u­la­tion on for­eign sub­sidies is head­ing for the fin­ish line - European...
Since 5 May 2022, EU tri­logue ne­go­ti­ations have been un­der­way on the first Reg­u­la­tion to lim­it the ef­fect of sub­sidies from third coun­tries to com­pan­ies act­ive in the EU. That an agree­ment will be reached...
Stock­holm Ar­bit­ra­tion Tribunal Denies Jur­is­dic­tion over In­tra-EU In­vest­ment...
In a ground­break­ing award, dated 16 June 2022, made in Green Power Part­ners K/S and SCE Sol­ar Don Benito APS v The King­dom of Spain, a tribunal con­sti­tuted un­der the Ar­bit­ra­tion Rules of the Ar­bit­ra­tion...
CMS Ex­pert Guide to refugee im­mig­ra­tion and travel re­quire­ments
Eng­lish (дивиться текст українською нижче)With the aim of provid­ing a single source of in­form­a­tion for Ukrain­i­an refugees con­sid­er­ing where they now go, the CMS em­ploy­ment...
The Gen­er­al Court of the EU con­firms the re­cov­ery of aid to Tir­renia di...
On 18 May 2022, the Gen­er­al Court of the EU con­firmed the leg­al­ity of the European Com­mis­sion's de­cision of 2 March 2020 con­cern­ing the re­cov­ery of il­leg­al and in­com­pat­ible aid gran­ted by Italy to the...
The United States Su­preme Court Re­stricts Dis­cov­ery for In­ter­na­tion­al Ar­bit­ra­tions
In a land­mark de­cision is­sued on 13 June 2022,[1] the US Su­preme Court (“SCOTUS”), Amer­ica’s highest court, ruled that the scope of Sec­tion 1782 of the United States Code (“U.S.C.”) does not...
Up­dated CMS Ex­pert Guide to Trade Secrets
From pat­ents to pro­grammes, designs to data, your most valu­able busi­ness as­sets can be the things you can’t put un­der lock and key. But what leg­al re­course do you have to pro­tect these in­tan­gible as­sets...
CMS Ex­pert Guide on rising raw ma­ter­i­al prices
Com­pan­ies in sev­er­al sec­tors are cur­rently faced with sig­ni­fic­ant in­creases in the price of raw ma­ter­i­als (in­clud­ing gas and pet­rol), or even short­ages in or tem­por­ary in­ter­rup­tions to sup­plies. These...
CMS ad­visor to Ger­man sportech eGym
CMS has ad­vised eGym, a Mu­nich-based Ger­man group that provides fit­ness fa­cil­it­ies with con­nec­ted equip­ment and apps, on the ac­quis­i­tion of French star­tup Gym­lib. Foun­ded in 2014, Gym­lib provides sports...
Up­date on the ap­plic­a­tion of “Mac­ron scale” by French judges in case of...
Thanks to a ma­jor re­form in 2017, a stat­utory scale de­term­ines the amount of dam­ages due to the em­ploy­ee in case of un­fair dis­missal (Art­icle L.1235-3 of the La­bour Code). This scale is not ap­plic­able...
CMS Ex­pert Guide to ad­verse ef­fects of drugs and vac­cines
The glob­al pan­dem­ic has ris­en a grow­ing aware­ness of the risks of ad­verse ef­fects of drugs and vac­cines. This un­ex­pec­ted event has put health­care pro­fes­sion­als in a situ­ation whereby the stand­ard pro­to­cols...
CMS Ex­pert Guide to trade secrets
As a busi­ness, your most val­ued as­sets can be the things you can’t touch or see. In­tan­gible as­sets such as pat­ents, for­mu­las, soft­ware, designs and data are now driv­ing cor­por­ate per­form­ance. And in...